Clinical Pharmacology

Bioanalysis, Biomarker and Flow Cytometry Assay List

Bioanalysis, Biomarker and Flow Cytometry Assay List. PRA Laboratories—Solutions for Drug Development. Behind every sample waiting to be analyzed,…

Sustainability

We’re committed to meaningfully integrating sustainability considerations into our business practices and culture. The work we do has a global…

Company History

A Blueprint to Success: Onboarding a Medical Writer

Onboarding is the process of welcoming new employees into an organization and providing them with the tools, resources, and knowledge to become…

Opportunities in low-level radiocarbon microtracing: applications and new technology

14C-radiolabeled (radiocarbon) drug studies are central to defining the disposition of therapeutics in clinical development. Concerns over radiation,…

Oral Abuse Potential of Benzhydrocodone, a Novel Prodrug of Hydrocodone

Hydrocodone bitartrate (HB) and acetaminophen (APAP) combination products are known to be abused via oral, intranasal, and intravenous…

ECG Assessments in Renal and Hepatic Impaired Patients

PRA’s dedicated early phase professionals leverage proven expertise in renal and hepatic impairment to provide clients with high quality ECG…

Select Characteristics of Recreational Opioid Users Undergoing a Human Abuse Potential Study

Human abuse potential (HAP) studies are conducted to determine the potential abuse of a drug that has rewarding properties. Abuse potential refers to…

Predicting Screen Failure Rates of Human Abuse Potential Studies

Human Abuse Potential (HAP) studies are required for New Drug Approvals of all drugs that have a potential psychoactive effect. The steps of…

Human Abuse Liability Studies: Not Your Traditional Phase I Study

Abuse potential refers to the likelihood for a drug to be used in nonmedical situations for its positive psychoactive effects. PRA Health Sciences’…